TUMOR SPECIFIC IMMUNE RESPONSIVENESS OF THE TUMOR BEARING HOST.BURK MW; YU S; MCKHANN CF et al.1976; ISRAEL J. MED. SCI.; ISRAEL; DA. 1976; VOL. 12; NO 4-5; PP. 360-368; BIBL. 13 REF.Article

ADHERENT CELLS IN TUMOR IMMUNITY.BURK MW; BURK KR; YU S et al.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 30; NO 1; PP. 43-53; BIBL. 11 REF.Article

SYSTEMIC ADMINISTRATION OF HUMAN LEUKOCYTE INTERFERON TO MELANOMA PATIENTS. I: EFFECTS ON NATURAL KILLER FUNCTION AND CELL POPULATIONSGOLUB SH; DOREY F; HARA D et al.1982; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 5; PP. 703-710; BIBL. 23 REF.Article

CLINICAL CORRELATIONS WITH DRUG SENSITIVITIES IN THE CLONOGENIC ASSAY: A RETROSPECTIVE STUDYMANN BD; KERN DH; GIULIANO AE et al.1982; ARCH. SURG. (CHIC.); ISSN 0004-0010; USA; DA. 1982; VOL. 117; NO 1; PP. 33-36; BIBL. 9 REF.Conference Paper

MONOCLONAL ANTIBODY AGAINST A₁ LEWIS D ANTIGEN PRODUCED BY THE HYBRIDOMA IMMUNIZED WITH A PULMONARY CARCINOMAIWAKI Y; KASAI M; TERASAKI PI et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 2; PP. 409-411; BIBL. 14 REF.Article